0001179110-13-011398.txt : 20130703 0001179110-13-011398.hdr.sgml : 20130703 20130703085104 ACCESSION NUMBER: 0001179110-13-011398 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130701 FILED AS OF DATE: 20130703 DATE AS OF CHANGE: 20130703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 02494 BUSINESS PHONE: 7814330771 MAIL ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 02494-2725 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Marucci Anthony S CENTRAL INDEX KEY: 0001429933 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15006 FILM NUMBER: 13951029 MAIL ADDRESS: STREET 1: 66 COLD HILL DRIVE CITY: MENDAHM STATE: NJ ZIP: 07945 4 1 edgar.xml FORM 4 - X0306 4 2013-07-01 0 0000744218 Celldex Therapeutics, Inc. CLDX 0001429933 Marucci Anthony S C/O CELLDEX THERAPEUTICS, INC. 119 FOURTH AVENUE NEEDHAM MA 02494 1 1 0 0 President & CEO Common Stock 2013-07-01 4 L 0 500 5.95 A 43368 D Incentive Stock Option 16.36 2013-07-01 4 A 0 280000 0 A 2014-07-01 2023-07-01 Common Stock 280000 280000 D 25% vest on July 1, 2014 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. /s/ Avery W. Catlin, attorney in fact for Anthony S. Marucci 2013-07-03